Royal Free Hospital, Royal Free London NHS Foundation Trust
North London teaching hospital that is a European Centre of Excellence for neuroendocrine tumours, where Martyn Caplin led the CLARINET trial of lanreotide.
Overview
The Royal Free Hospital in Hampstead is the main site of the Royal Free London NHS Foundation Trust and a teaching hospital of University College London. Its Neuroendocrine Tumour Unit, led by Martyn Caplin, is an ENETS Centre of Excellence and coordinated CLARINET, the 2014 New England Journal of Medicine trial in which lanreotide lengthened progression-free survival in non-functioning enteropancreatic neuroendocrine tumours. The hospital is also a national centre for liver transplantation and hepatobiliary cancer.
- Neuroendocrine tumours (ENETS Centre of Excellence)
- Hepatobiliary cancer
- Liver transplantation
Similar pages
not linked directly; found by shared links- TrialCLARINET
Shares Martyn E. Caplin, Neuroendocrine tumours.
- JournalEndocrine-related cancer
Shares Martyn E. Caplin, Neuroendocrine tumours.